Cat. #151660
Anti-TAL1 [2TL75]
Cat. #: 151660
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: TAL1
Class: Monoclonal
Application: IHC ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Karen Pulford
Institute: University of Oxford
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-TAL1 [2TL75]
- Research fields: Cancer;Cell biology;Developmental biology;Genetics;Stem cell biology
- Clone: 2TL75
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: IHC ; IP
- Description: TAL-1 is a member of the helix-loop-helix family of transcription factors. Overexpression of the TAL-1 gene is the most common molecular abnormality found in human T cell leukaemia.
- Immunogen: Recombinant protein
- Isotype: IgG1 kappa
- Myeloma used: P3/NS1/1-Ag4.1
Target Details
- Target: TAL1
- Target background: TAL-1 is a member of the helix-loop-helix family of transcription factors. Overexpression of the TAL-1 gene is the most common molecular abnormality found in human T cell leukaemia.
Applications
- Application: IHC ; IP
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Delabesse et al. 1998. Br J Haematol. 102(2):449-57. PMID: 9695959.
- TAL1 expression does not occur in the majority of T-ALL blasts.
- Bernard et al. 1995. Blood. 85(11):3356-7. PMID: 7756670.
- Nuclear localization of the SCL/TAL1 basic helix-loop-helix protein is not dependent on the presence of the basic domain.
- Pulford et al. 1995. Blood. 85(3):675-84. PMID: 7833471.
- Expression of TAL-1 proteins in human tissues.
